PHARMAX OS LLC
PHARMAX OS LLC
Information about the company PHARMAX OS LLC with a registered address in Trinity, Florida.
Company address
- Company name:
- PHARMAX OS LLC
- Address:
- 10541 SABELLA DR, TRINITY, 34655
- City:
- Trinity
- County:
- Pasco County
- Region:
- West Central Florida
- State:
- Florida
Entity information
- Entity Type:
- Florida Limited Liability Co.
- Entity ID:
- L26000251053
- Formation Date:
- 2026-05-04
- Last known update record:
- 2026-05-04
PHARMAX OS LLC on the map
Other information
- Registered Agent:
- HABIB RAAFAT10541 SABELLA DRTRINITY, FL 34655
- Registered Mailing Address:
- 10541 SABELLA DRTRINITY, FL 34655
- Address:
- 10541 SABELLA DR, TRINITY, 34655
- Principals:
- HABIB RAAFAT (AMBR)10541 SABELLA DRTRINITY, FL 34655
- PIGNANO ITALO (AMBR)1801 N MORGAN STTAMPA, FL 33602
- LINAHAN CHRIS (AMBR)10745 E DIFFRACTION AVEMEZNA, AZ 85212
Frequently asked questions
What is PHARMAX OS LLC?
PHARMAX OS LLC is a florida limited liability co. registered in Florida on 2026-05-04, with entity ID L26000251053.
Where is PHARMAX OS LLC located?
The company's registered address is 10541 SABELLA DR, TRINITY, 34655, Trinity, Florida — in Pasco County, West Central Florida.
Who is the registered agent of PHARMAX OS LLC?
HABIB RAAFAT is listed as the registered agent at 10541 SABELLA DR, TRINITY, FL 34655.
Who are the principals of PHARMAX OS LLC?
The filed principals are HABIB RAAFAT (AMBR), PIGNANO ITALO (AMBR), LINAHAN CHRIS (AMBR).
What is the entity type of PHARMAX OS LLC?
PHARMAX OS LLC is registered as a Florida Limited Liability Co. in the State of Florida.
When was PHARMAX OS LLC formed?
PHARMAX OS LLC was formed on 2026-05-04. The most recent known record update is 2026-05-04.
What is the entity ID of PHARMAX OS LLC?
The official Florida entity ID (Document Number) for PHARMAX OS LLC is L26000251053.
Is PHARMAX OS LLC active?
Based on the latest update on 2026-05-04, PHARMAX OS LLC is listed in the Florida business registry. Always verify the current status on the official state filing.